Someone with a lot of money to spend has taken a bullish stance on Immunovant IMVT.
And retail traders should know.
We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.
Whether this is an institution or just a wealthy individual, we don't know. But when something this big happens with IMVT, it often means somebody knows something is about to happen.
So how do we know what this whale just did?
Today, Benzinga's options scanner spotted 16 uncommon options trades for Immunovant.
This isn't normal.
The overall sentiment of these big-money traders is split between 50% bullish and 50%, bearish.
Out of all of the special options we uncovered, 3 are puts, for a total amount of $333,180, and 13 are calls, for a total amount of $845,434.
What's The Price Target?
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $15.0 to $35.0 for Immunovant over the last 3 months.
Volume & Open Interest Development
In terms of liquidity and interest, the mean open interest for Immunovant options trades today is 5448.86 with a total volume of 14,140.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Immunovant's big money trades within a strike price range of $15.0 to $35.0 over the last 30 days.
Immunovant Option Volume And Open Interest Over Last 30 Days
Biggest Options Spotted:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|
| IMVT | PUT | TRADE | BEARISH | 10/20/23 | $15.00 | $253.2K | 12.0K | 4.4K |
| IMVT | CALL | TRADE | BEARISH | 10/20/23 | $30.00 | $160.3K | 611 | 5.0K |
| IMVT | CALL | TRADE | NEUTRAL | 01/19/24 | $25.00 | $146.0K | 333 | 400 |
| IMVT | CALL | TRADE | BULLISH | 01/19/24 | $25.00 | $146.0K | 333 | 200 |
| IMVT | CALL | SWEEP | BEARISH | 12/15/23 | $25.00 | $56.2K | 2.4K | 79 |
Where Is Immunovant Standing Right Now?
- With a volume of 2,096,133, the price of IMVT is down -4.05% at $20.39.
- RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.
- Next earnings are expected to be released in 42 days.
What The Experts Say On Immunovant:
- Guggenheim downgraded its action to Buy with a price target of $32
- Cantor Fitzgerald downgraded its action to Overweight with a price target of $30
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Immunovant, Benzinga Pro gives you real-time options trades alerts.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
